These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 17646678)
1. Impact of Pycnogenol on cardiac extracellular matrix remodeling induced by L-NAME administration to old mice. Zibadi S; Yu Q; Rohdewald PJ; Larson DF; Watson RR Cardiovasc Toxicol; 2007; 7(1):10-8. PubMed ID: 17646678 [TBL] [Abstract][Full Text] [Related]
2. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA. Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821 [TBL] [Abstract][Full Text] [Related]
3. Hesperidin Prevents Nitric Oxide Deficiency-Induced Cardiovascular Remodeling in Rats via Suppressing TGF-β1 and MMPs Protein Expression. Maneesai P; Bunbupha S; Potue P; Berkban T; Kukongviriyapan U; Kukongviriyapan V; Prachaney P; Pakdeechote P Nutrients; 2018 Oct; 10(10):. PubMed ID: 30347737 [TBL] [Abstract][Full Text] [Related]
4. Carthamus Tinctorius L. extract attenuates cardiac remodeling in L-NAME-induced hypertensive rats by inhibiting the NADPH oxidase-mediated TGF-β1 and MMP-9 pathway. Bunbupha S; Pakdeechote P; Maneesai P; Prachaney P; Boonprom P Ann Anat; 2019 Mar; 222():120-128. PubMed ID: 30590121 [TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Bourraindeloup M; Adamy C; Candiani G; Cailleret M; Bourin MC; Badoual T; Su JB; Adubeiro S; Roudot-Thoraval F; Dubois-Rande JL; Hittinger L; Pecker F Circulation; 2004 Oct; 110(14):2003-9. PubMed ID: 15451797 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway. Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696 [TBL] [Abstract][Full Text] [Related]
7. Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition. Hale SA; Weger L; Mandala M; Osol G Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1266-75. PubMed ID: 21856919 [TBL] [Abstract][Full Text] [Related]
8. Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. Jin L; Lin MQ; Piao ZH; Cho JY; Kim GR; Choi SY; Ryu Y; Sun S; Kee HJ; Jeong MH J Hypertens; 2017 Jul; 35(7):1502-1512. PubMed ID: 28234674 [TBL] [Abstract][Full Text] [Related]
9. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction. Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency. Yamashita T; Yamamoto E; Kataoka K; Nakamura T; Matsuba S; Tokutomi Y; Dong YF; Ichijo H; Ogawa H; Kim-Mitsuyama S Hypertension; 2007 Sep; 50(3):519-24. PubMed ID: 17646574 [TBL] [Abstract][Full Text] [Related]
11. Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats. Hsu YH; Hsu BG; Chen HI Chin J Physiol; 2007 Dec; 50(6):283-93. PubMed ID: 18442011 [TBL] [Abstract][Full Text] [Related]
12. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Spinale FG; Coker ML; Bond BR; Zellner JL Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226 [TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405 [TBL] [Abstract][Full Text] [Related]
14. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor. de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis. Kazakov A; Hall R; Jagoda P; Bachelier K; Müller-Best P; Semenov A; Lammert F; Böhm M; Laufs U Cardiovasc Res; 2013 Nov; 100(2):211-21. PubMed ID: 23863197 [TBL] [Abstract][Full Text] [Related]
16. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Henderson BC; Sen U; Reynolds C; Moshal KS; Ovechkin A; Tyagi N; Kartha GK; Rodriguez WE; Tyagi SC Int J Biol Sci; 2007 Sep; 3(6):385-92. PubMed ID: 17848984 [TBL] [Abstract][Full Text] [Related]
17. Endothelin and gelatinases in renal changes following blockade of nitric oxide synthase in hypertensive rats. Yang YL; Liu DD; Hsieh NK; Chen HI Chin J Physiol; 2008 Jun; 51(3):186-95. PubMed ID: 18935914 [TBL] [Abstract][Full Text] [Related]